CD4 and cancer: In our study, the lower ratio of CD4/CD8, with significantly fewer CD4+ T cells but no significant difference in CD8+ T cells in patients with more aggressive disease supports the role of CD4+ cytotoxic and helper T cells in mediating immune response against cancer cells.